| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $87.9M | +4.9% |
| R&D Expense | $134.7M | +51.6% |
| SG&A Expense | $358.8M | +31.6% |
| Operating Income | -$263.6M | +7.7% |
| Pre-tax Income | -$256.3M | +9.8% |
| Income Tax | $6K | +6.6% |
| Net Income | -$256.3M | +9.8% |
| EPS (Basic) | -$2.72 | +22.3% |
| EPS (Diluted) | -$2.72 | +22.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $148.6M | +60.9% |
| Accounts Receivable | $75.2M | +273.0% |
| Inventory | $23.9M | +201.0% |
| Current Assets | $738.0M | +57.9% |
| Total Assets | $754.8M | +54.1% |
| Current Liabilities | $83.2M | +56.0% |
| Total Liabilities | $98.7M | +37.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$270.2M | -4.1% |
| Capital Expenditures | $778K | +138.8% |
| Investing Cash Flow | -$128.4M | -145.8% |
| Financing Cash Flow | $455.2M | +3851.4% |
| Free Cash Flow | -$271.0M | -4.3% |
| Stockholders' Equity |
| $656.1M |
| +57.0% |